A regional audit of iatrogenic perforation of tumours of the oesophagus and cardia

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 4, 2005, Pages 479-484

  Jethwa, P ^a   Lala, A ^b   Powell, J ^a   McConkey, C C ^c   Gillison, E W ^b   Spychal, R T ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CARDIA CARCINOMA; DIATHERMY; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS DILATATION; ESOPHAGUS PERFORATION; FEMALE; HUMAN; IATROGENIC DISEASE; LAPAROTOMY; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; STENT; SURGICAL DRAINAGE;

AGED; CARDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL PERFORATION; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 14644415481     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02324.x     Document Type: Article

References (28)

1. Powell J, McConkey CC, Gillison EW, Spychal RT. Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 2002; 102: 422-7.
2. Kocher HM, Linklater K, Patel S, Ellul JP. Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg 2001; 88: 1249-57.
3. Cancer Research UK. http://www.cancerresearchuk.org/aboutcancer/ statistics/incidence, UK Incidence cancer 1999. Cancer Research UK, 2003.
4. Frenken M. Best palliation in esophageal cancer: surgery, stenting, radiation, or what? Dis Esophagus 2001; 14: 120-3.
5. Mason R. Palliation of oesophageal cancer. Surgical Oncology 2001; 10: 123-6.
6. Tytgat GN, Bartelink H, Bernards R, et al. Cancer of the esophagus and gastric cardia: recent advances*. Dis Esophagus 2004; 17: 10-26.
7. Gillison EW, Powell J, McConkey CC, Spychal RT. Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg 2002; 89: 344-8.
8. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998; 85: 840-4.
9. Quine MA, Bell GD, McCloy RF, Matthews HR. Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg 1995; 82: 530-3.
10. Aste H, Munizzi F, Marlines H, Pugliese V. Esophageal dilatation in malignant dysphagia. Cancer 1985; 56: 2713-5.
11. Lundell L, Leth R, Lind T. Palliative dilatation in carcinoma of the esophagus and esophagogastric junctions. Acta Chir Scand 1989; 155: 179-84.
12. Riley SA, Attwood SE. Guidelines on the use of oesophageal dilatation in clinical practice. Gut 2004; 53(Suppl. 1): i1-6.
13. Knyrim K, Wagner HJ, Bethge N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 329: 1302-7.
14. De Palma GD, Matteo ED, Romano G. Plastic prothesis versus expandable metal stents for palliation of inoperable thoracic carcinoma: a controlled prospective study. Gastrointest Endosc 1996; 43: 478-82.
15. Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest Endoscopy 1998; 47: 113-20.
16. Sanyika C, Corr P, Haffejee A. Palliative treatment of oesophageal carcinoma - efficacy of plastic versus self expandable stents. S Afr Med 1999; 89: 640-3.
17. Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. GUT 2003; 52: 922-6.
18. Gukovsky-Reicher S, Lin RM, Sial S, et al. Self-expandable metal stents in palliation of malignant gastrointestinal obstruction: review of the current literature data and 5-year experience at Harbor-UCLA Medical Center. MedGenMed 2003; 5: 16.
19. Wang MQ, Sze DY, Wang ZP, Wang ZQ, Gao YA, Dake MD. Delayed complications after esophageal stent placement for treatment of malignant esophageal obstructions and esophagorespiratory fistulas. J Vasc Interv Radiol 2001; 12: 465-74.
20. Moses FM, Wong RK. Stents for esophageal disease. Curr Treat Options Gastroenterol 2002; 5: 63-71.
21. Cwikiel W, Tranberg KG, Cwikiel M, Lillo-Gil R. Malignant dysphagia: palliation with esophageal stents - long-term results in 100 patients. Radiology 1998; 207: 513-8.
22. Watson A. Self-expanding metal oesophageal endoprostheses: which is best? Eur J Gastroenterol Hepatol 1998; 10: 363-5.
23. Tyrrell MR, Trotter GA, Adam A, Mason RC. Incidence and management of laser-associated oesophageal perforation. Br J Surg 1995; 82: 1257-8.
24. Eriksen JR. Palliation of non-resectable carcinoma of the cardia and oesophagus by argon beam coagulation. Dan Med Bull 2002; 49: 346-9.
25. Heindorff HWM, Bisgaard T, Svendsen LB. Endoscopic palliation of inoperable cancer of the oesophagus or cardia by argon electrocoagulation. Scand J Gastroenterol 1998; 33: 21-3.
26. Spiller RC, Misiewicz JJ. Ethanol-induced tumour necrosis for palliation of malignant dysphagia. Lancet 1987; 2: 792.
27. Carazzone A, Bonavina L, Segalin A, Ceriani C, Peracchia A. Endoscopic palliation of oesophageal cancer: results of a prospective comparison of Nd:YAG laser and ethanol injection. Eur J Surg. 1999 Related Articles, Links 1999; 165: 351-6.
28. Robertson GSTM, Jamieson J, Veitch PS, Dennison AR. Palliation of oesophageal carcinoma using the argon beam coagulator. Br J Surg 1996; 83: 1769-71.